Search

everythinglearnresearchcommunity

for

Search:↓

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Promising cancer treatments were found, but the manufacturer closed.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Ixekizumab has known and some unexpected side effects.

Vaccination is crucial for managing Covid-19 despite new virus strains.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

The FDA rejected a testosterone drug again due to safety concerns.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Continued vaccine and drug development is crucial due to new virus variants and regional infection spikes.